Separate current trading from historical accounts
The latest selected financial period is 2022-12-31. A recent market quote or a new scoring timestamp does not update those accounts.
—
—
—
Creso Pharma
—
—
Live Price
CIN RESEARCH · DATED EVIDENCE
Historical financial evidenceCreso Pharma: newer financial reporting is the missing piece.
The available financial series reaches December 31, 2022; current financial conclusions are withheld.
Latest financial observation 2022-12-31Price history through 2023-08-10Research checked 2026-11-07 13:30 UTC
The check time records a research refresh. Each financial figure and price keeps its own reporting date.
Reported financial evidence
| Measure | Reported value & unit | Period & interval | Evidence basis |
|---|---|---|---|
| RevenueHistorical observation | AUD 8.69mUnit: AUD | Annual period | Dated financial series |
| Cost of revenueHistorical observation | AUD 8.4mUnit: AUD | Annual period | Dated financial series |
| Gross profitHistorical observation | AUD 287,000Unit: AUD | Annual period | Dated financial series |
| Operating incomeHistorical observation | AUD -19.57mUnit: AUD | Annual period | Dated financial series |
| EBITDAHistorical observation | AUD -17.62mUnit: AUD | Annual period | Dated financial series |
| Net incomeHistorical observation | AUD -32.78mUnit: AUD | Annual period | Dated financial series |
| Cash balanceHistorical observation | AUD 1.39mUnit: AUD | Balance at period end | Dated financial series |
| Total assetsHistorical observation | AUD 37.98mUnit: AUD | Balance at period end | Dated financial series |
| Total liabilitiesHistorical observation | AUD 15.69mUnit: AUD | Balance at period end | Dated financial series |
| Shareholders’ equityHistorical observation | AUD 22.29mUnit: AUD | Balance at period end | Dated financial series |
| Operating cash flowHistorical observation | AUD -30.83mUnit: AUD | Annual period | Dated financial series |
| Free cash flowHistorical observation | AUD -31.18mUnit: AUD | Annual period | Dated financial series |
A balance at period end is not income over a period. “Quarterly series” follows the available classification; the source disclosure establishes the actual reporting interval.
What to investigate next
- Resolve the conflicting financial observations against the primary report.
- Locate a newer primary financial report and reconcile its units before making a current company assessment.
Evidence boundaries
- Conflicting observations for the same concept, period and reporting basis are withheld.
- The newest available revenue observation is historical on its supplied reporting basis. A current revenue assessment is withheld.
- No dated primary company disclosures were supplied; absence in this feed is not a clean regulatory check.
- The earlier rating is not presented as a current conclusion. This report is rebuilt from dated evidence.
Independent evidence summary. No broker consensus, price target or investment rating is manufactured. Research standards →
Price History · currency not supplied
5 Years
Fundamentals
SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
CONTINUE YOUR RESEARCH